The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Midazolam for aggressivity and violence in three mentally retarded patients

Published Online:https://doi.org/10.1176/ajp.146.7.925

Midazolam was administered to three mentally retarded patients with acute and refractory aggressivity and violence. Midazolam was well tolerated without complications and provided dramatic control of the symptoms, suggesting an expanded role for it in the management of aggressive and violent behavior.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.